Investor Lists

PE firms backing Genomics

Updated 7 November 2026

PE firms we have observed in a genomics round in the last two years.

See all 53 →The top 25
53investors on the list+3 this week
546cheques in 12 months+49% against the market
$111Mmedian round they joined+1288% against the market median
89%wrote a cheque in 12 months
66%have led a round

The Top 25

Ordered by cheques observed, never by anything anyone paid for

Deploying now (23)

  1. 1RA Capital ManagementDeploying nowPrivate equity · United States395$93Mmedian roundNov 2026last seen
  2. 2HSBCDeploying nowGrowth equity · United Kingdom234$45Mmedian roundOct 2026last seen
  3. 3Franklin TempletonDeploying nowPrivate equity · United States198$64Mmedian roundNov 2026last seen
  4. 4Janus Henderson InvestorsDeploying nowPrivate equity · United Kingdom178$115Mmedian roundOct 2026last seen
  5. 5InvusDeploying nowPrivate equity · United States148$81Mmedian roundOct 2026last seen
  6. 6Vivo CapitalDeploying nowPrivate equity · United States140$64Mmedian roundSept 2026last seen
  7. 7T. Rowe PriceDeploying nowPrivate equity · United States136$400Mmedian roundNov 2026last seen
  8. 8Forbion Capital PartnersDeploying nowPrivate equity · Netherlands134$88Mmedian roundOct 2026last seen
  9. 9WndrCoDeploying nowPrivate equity · United States114$15Mmedian roundSept 2026last seen
  10. 10Novo Holdings A/SquietGrowth equity93$40Mmedian roundMar 2025last seen
  11. 11AlibabaDeploying nowGrowth equity · United States83$150Mmedian roundOct 2026last seen
  12. 12Eastern Bell CapitalDeploying nowPrivate equity · China72$15Mmedian roundJul 2026last seen
  13. 13Breyer CapitalDeploying nowPrivate equity · United States69$24Mmedian roundOct 2026last seen
  14. 14Bain CapitalDeploying nowPrivate equity · United States58$50Mmedian roundAug 2026last seen
  15. 15UI InvestissementDeploying nowPrivate equity · France52$5.6Mmedian roundJul 2026last seen
  16. 16Bain Capital Life SciencesDeploying nowPrivate equity · United States49$134Mmedian roundOct 2026last seen
  17. 1714WDeploying nowPrivate equity · United States35$25Mmedian roundAug 2026last seen
  18. 18EQTDeploying nowPrivate equity · Sweden35$62Mmedian roundSept 2026last seen
  19. 19Johnson & Johnson InnovationDeploying nowGrowth equity24$43Mmedian roundJun 2026last seen
  20. 20Samsung ElectronicsDeploying nowGrowth equity · South Korea18$145Mmedian roundSept 2026last seen
  21. 21• Ark InvestDeploying nowGrowth equity · Georgia17$540Mmedian roundNov 2026last seen
  22. 22Turenne CapitalquietPrivate equity · France11$24Mmedian roundJan 2025last seen
  23. 23PSP GrowthDeploying nowPrivate equity · United States9$60Mmedian roundNov 2026last seen
  24. 24BroadLight CapitalDeploying nowPrivate equity · United States6$250Mmedian roundAug 2026last seen
  25. 25FigmaDeploying nowGrowth equity · United States6$41Mmedian roundFeb 2026last seen
28 more on this list

All 53 are in the app, with filters for stage, sector and market. A free account shows 10 per search, Pro up to 1,000.

See the whole list →

Quick answers about PE firms backing Genomics

Who are the most active PE firms backing Genomics?

By cheques observed, the most active are RA Capital Management, HSBC, Franklin Templeton, Janus Henderson Investors and Invus.

How many PE firms backing Genomics are there?

53 are on record. 89% made an investment in the last 12 months and 66% have led a round.

Which stages do PE firms backing Genomics back?

Of the rounds with a named stage in the last 12 months, mostly Debt (22%) and Series A (21%).

How big are the rounds PE firms backing Genomics join?

The typical (median) round among the leading investors here is $62M.

Which sectors do PE firms backing Genomics back most?

In the last 12 months, mostly Biotech, AI and Pharma.

Which PE firms backing Genomics lead the most rounds?

RA Capital Management (15 led), T. Rowe Price (11 led) and Forbion Capital Partners (10 led).

Where are PE firms backing Genomics based?

Among the most active, most are based in the United States (14), the United Kingdom (2) and France (2).

What have PE firms backing Genomics invested in recently?

Recent rounds include aSand.ai (Series A, Nov 2026, with Co-Stone Capital), Ocient (Series C, Nov 2026, with PSP Growth) and Soter Insure (Series B, Nov 2026, with Franklin Templeton).

Built from the rounds we watched, refreshed every night. How we count · Report a correction